OnlineBusinessBureau.com
We are not the Better Business Bureau. We're better!
 
   About Us
   Our Ratings
   Look up a Company
   File a Complaint
   Complaint Resolution
     Center
   Resources
   Membership - Join Now!
   Member Login
   Testimonials
   Contact Us

1,847,074 companies
in our database.

Join our weekly
Consumer Fraud
Alert Newsletter



Our members proudly
display this seal!

News Releases

Back

New Report Available: Piramal Enterprises Limited - Product Pipeline Review - 2014

Global Markets Direct's, 'Piramal Enterprises Limited - Product Pipeline Review - 2014', provides an overview of the Piramal Enterprises Limited's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Piramal Enterprises Limited's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Full Report Details at
 - http://www.fastmr.com/prod/933145_piramal_enterprises_limited_product_pipeline.aspx?afid=101

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

 * The report provides brief overview of Piramal Enterprises Limited including business description, key information and facts, and its locations and subsidiaries
 * The report reviews current pipeline of Piramal Enterprises Limited's human therapeutic division and enlists all their major and minor projects
 * The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
 * Special feature on out-licensed and partnered product portfolio
 * The report summarizes all the dormant and discontinued pipeline projects
 * Latest company statement
 * Latest news and deals relating to the Piramal Enterprises Limited's pipeline products

Reasons to Get this Report

 * Evaluate Piramal Enterprises Limited's strategic position with total access to detailed information on its product pipeline
 * Assess the growth potential of Piramal Enterprises Limited in its therapy areas of focus
 * Identify new drug targets and therapeutic classes in the Piramal Enterprises Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
 * Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
 * Develop strategic initiatives by understanding the focus areas of Piramal Enterprises Limited and exploit collaboration and partnership opportunities
 * Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
 * Plan mergers and acquisitions effectively by identifying the most promising pipeline of Piramal Enterprises Limited
 * Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
 * Explore the dormant and discontinued projects of Piramal Enterprises Limited and identify potential opportunities in those areas
 * Avoid Intellectual Property Rights related issues

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Piramal Enterprises Limited Snapshot
Piramal Enterprises Limited Overview
Key Information
Key Facts
Piramal Enterprises Limited - Research and Development Overview
Key Therapeutic Areas
Piramal Enterprises Limited - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Piramal Enterprises Limited - Pipeline Products Glance
Piramal Enterprises Limited - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Piramal Enterprises Limited - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Piramal Enterprises Limited - Drug Profiles
P-276
Product Description
Mechanism of Action
R&D Progress
P-1736
Product Description
Mechanism of Action
R&D Progress
P-1446
Product Description
Mechanism of Action
R&D Progress
P-11187
Product Description
Mechanism of Action
R&D Progress
P-2745
Product Description
Mechanism of Action
R&D Progress
P-7435
Product Description
Mechanism of Action
R&D Progress
P-3971
Product Description
Mechanism of Action
R&D Progress
P-7170
Product Description
Mechanism of Action
R&D Progress
P-979
Product Description
Mechanism of Action
R&D Progress
PM-181104
Product Description
Mechanism of Action
R&D Progress
PM-181108
Product Description
Mechanism of Action
R&D Progress
Small Molecule for Cancer
Product Description
Mechanism of Action
R&D Progress
Piramal Enterprises Limited - Pipeline Analysis
Piramal Enterprises Limited - Pipeline Products by Target
Piramal Enterprises Limited - Pipeline Products by Route of Administration
Piramal Enterprises Limited - Pipeline Products by Molecule Type
Piramal Enterprises Limited - Pipeline Products by Mechanism of Action
Piramal Enterprises Limited - Recent Pipeline Updates
Piramal Enterprises Limited - Dormant Projects
Piramal Enterprises Limited - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
P-1201
P-276
PM-181110

Full Table of Contents is available at:
-- http://www.fastmr.com/prod/933145_piramal_enterprises_limited_product_pipeline.aspx?dt=t&afid=101

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available.  Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

 


Credit Secrets Bible

Get Paid for
Doing Surveys





The Online Business Bureau -- 21441 Pacific Boulevard -- Suite 200 -- Sterling, VA 20166 -- 202-558-5282
News Releases |  News Articles |  Financial Calculators |  Contact Us |  Privacy Policy | Terms of Use & Legal Notice
Copyright © 2018 Online Business Bureau, L. C.. All Rights Reserved.
We are not affiliated with the Council of Better Business Bureaus, Inc.